InsidersTradesSigma
Laurus Labs Limited: directors' dealings · India · SEBI (PIT + SAST)
SEBI:laurus-labs-limitedIN·SEBI (PIT + SAST)Mcap 331.0Bn€
Explore the full insider trade history of Laurus Labs Limited, a listed issuer based in India. Shares are quoted on IN IN, under the supervision of SEBI (PIT + SAST). Market capitalisation: €331bn. The latest transaction was filed on 6 December 2024 (Pledge). Among the most active insiders: NURUBHASHA BABCHAND. The full history is accessible without an account.
94
Insider Decl.
0
Thresholds
€230,889
9 ops.
Buy Volume
€11m
63 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
1327.30 €
Income statement
Revenue55.08 Bn€
Gross profit29.68 Bn€54% margin
Net income3.58 Bn€6.5% margin
Balance sheet & cash
Market cap330.99 Bn€
Total debt27.64 Bn€
Free Cash Flow−393.5 M€
Last declaration on 6 December 2024
Declarations94 total
Executives●Pledge7SEBI
€1m200,000 shares@ €6.380253.2% of flow
Equity Shares
SEBI:f056e113b6d76c2ca2150ffbc16b0d83f54e802b·
Executives●Sale0SEBI
€42,41310,000 shares@ €4.2413
Equity Shares
SEBI:65a5ebe59fea5b64a320934230be0c60f5938025·
Executives●Purchase0SEBI
€27,5883,992 shares@ €6.9108
Equity Shares
SEBI:533ed4ab7f20b74154ba14b1ace39f1f40980e44·
Ideal exit: 11 Dec 2022 (T+270)
Executives●Purchase0SEBI
€20,1252,906 shares@ €6.9253
Equity Shares
SEBI:f42d38f3df2b5437d430c3531e677c3a8b4b41c6·
Ideal exit: 9 Dec 2022 (T+270)
Executives●Purchase0SEBI
€5,424788 shares@ €6.8836
Equity Shares
SEBI:3366fdec688fd4954445e2ed651c1ee188c066c3·
Ideal exit: 12 Dec 2022 (T+270)
Executives●Sale0SEBI
€14,1852,275 shares@ €6.2351
Equity Shares
SEBI:9918aa918bf48f376276e65749d72798b1cc2fd3·
Executives●Purchase0SEBI
€63,00610,000 shares@ €6.3006
Equity Shares
SEBI:38648633ccebbcc5b348287b244fdaf2237aa5f6·
Ideal exit: 12 Nov 2022 (T+270)
Executives●Pledge0SEBI
€60,80210,245 shares@ €5.9348
Equity Shares
SEBI:3c64216c2911c4481747e64cfffb129684c055bf·
Executives●Sale0SEBI
€91,12412,000 shares@ €7.5937
Equity Shares
SEBI:89cce66f57a00d5b944c713995d2af8d7b6e43a9·
Executives●Sale0SEBI
€7,3721,000 shares@ €7.3716
Equity Shares
SEBI:70dd415dbf1f2fff1e417e60f5b64c1724e22ace·
Executives●Sale0SEBI
€29,9804,000 shares@ €7.4951
Equity Shares
SEBI:38a73e3679e9a0368c34fa465ac3b651400cd155·
Executives●Sale11SEBI
€41,4185,500 shares@ €7.53050.0000% mcap100.0% of flow
Equity Shares
SEBI:3b480afbc23a058629b405c641fa3064b07d5c5c·
Executives●Sale11SEBI
€22,7873,000 shares@ €7.59580.0000% mcap100.0% of flow
Equity Shares
SEBI:69648c1b026d439e29642d979c59be7d7a2381e4·
Executives●Sale3SEBI
€145,93618,120 shares@ €8.05390.0000% mcap4.9% of flow
Equity Shares
SEBI:47edc5b96d5919ef4a2dcb5a7d387403d19e4e4c·
Executives●Sale4SEBI
€160,32820,000 shares@ €8.01640.0000% mcap5.3% of flow
Equity Shares
SEBI:b764e1f7fab1b1c9f44ecd5b7252fd53243b16b9·
Executives●Sale5SEBI
€546,08167,657 shares@ €8.07130.0002% mcap18.2% of flow
Equity Shares
SEBI:8679313bcf167fe661ae23babba4951a458450ed·
Executives●Sale8SEBI
€11,5761,445 shares@ €8.0110.0000% mcap50.1% of flow
Equity Shares
SEBI:ff4d7d5e25c0c2d0470fdb1a36453dbb2b20936d·
Executives●Purchase7SEBI
€22,7052,910 shares@ €7.80240.0000% mcap36.5% of flow
Equity Shares
SEBI:d7094110df1c126fb2f2988a96abed8cbf40527c·
Ideal exit: 27 Mar 2022 (T+270)
Executives●Pledge9SEBI
€39,4805,060 shares@ €7.80240.0000% mcap63.5% of flow
Equity Shares
SEBI:d841479378fac38ef620176828126f861f5e726f·
Executives●Pledge8SEBI
€155,44820,000 shares@ €7.77240.0000% mcap50.0% of flow
Equity Shares
SEBI:db9fb14bf57d4a899c78847d77441a2534d75dca·
Executives●Sale11SEBI
€50,5846,500 shares@ €7.78220.0000% mcap89.0% of flow
Equity Shares
SEBI:bca8cc04a27c9c9810a2152f45418010ba142aa3·
Executives●Sale11SEBI
€116,81215,000 shares@ €7.78750.0000% mcap100.0% of flow
Equity Shares
SEBI:c1c3cddf953e72821edf1b79140eee6568300dff·
Executives●Sale10SEBI
€771,722100,000 shares@ €7.71720.0002% mcap68.8% of flow
Equity Shares
SEBI:cca0346f49eb11a88e6d509fba87315a476c63c6·
Executives●Sale4SEBI
€6,2721,500 shares@ €4.18110.0000% mcap11.0% of flow
Equity Shares
SEBI:3416b6b38ae404ebeaeeebb5147776a5a23dd514·
25 of 94 declarations
About Laurus Labs Limited
Laurus Labs Limited is an Indian pharmaceutical company engaged in the research, development, and manufacturing of generic pharmaceutical products. It primarily focuses on antiretroviral drugs and healthcare products.